Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2022
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...
Source: prnewswire.com